2'-OTBS N3-Me-U amidite

Catalog No. :
ACKQIG043
CAS No. :
179762-50-6
Molecular Formula :
C46H63N4O9PSi
Molecular Weight :
875.09

IUPAC Name:(2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

2'-OTBS N3-Me-U amidite structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$415.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2'-OTBS N3-Me-U amidite
IUPAC Name(2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-((tert-butyldimethylsilyl)oxy)-5-(3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
Molecular FormulaC46H63N4O9PSi
Molecular Weight875.09
SMILESCC(C)N(C(C)C)P(OCCC#N)O[C@@H]([C@H]([C@H](N1C(N(C(C=C1)=O)C)=O)O2)O[Si](C)(C)C(C)(C)C)[C@H]2COC(C3=CC=C(C=C3)OC)(C4=CC=CC=C4)C5=CC=C(C=C5)OC
InChI KeyBFLRLATZTWPEAW-SRYSXPHVSA-N
Synonym2'-O-tert-Butyldimethylsilyl-5'-O-DMT-3-methyluridine 3'-CE phosphoramidite;Uridine, 5'-?O-?[bis(4-?methoxyphenyl)?phenylmethyl]?-?2'-?O-?[(1,?1-?dimethylethyl)?dimethylsilyl]?-?3-?methyl-?, 3'-?[2-?cyanoethyl bis(1-?methylethyl)?phosphoramidite] (9CI)
CAS No.179762-50-6

Synthetic Route by SureRoute

1. ACKQIG043 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXACF682 route compound structure diagram
    ACXACF682109-78-4 In Stock
  4. Then
  5. ACKQIG043 route product structure diagram
    ACKQIG043179762-50-6
Inquiry

2. ACKQIG043 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKQIG043 route product structure diagram
    ACKQIG043179762-50-6
Inquiry

Comments (0)